Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Natera, Inc. - Common Stock
(NQ:
NTRA
)
212.72
+9.68 (+4.77%)
Streaming Delayed Price
Updated: 10:23 AM EST, Feb 9, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Natera, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
...
19
20
Next >
NCCN Strengthens Guidance on ctDNA in Colon Cancer, Rectal Cancer, and Merkel Cell Carcinoma
February 10, 2025
From
Natera, Inc.
Via
Business Wire
$100 Invested In Natera 5 Years Ago Would Be Worth This Much Today
↗
February 06, 2025
Via
Benzinga
Natera Announces National Commercial Coverage for its Fetal RhD NIPT
February 03, 2025
From
Natera, Inc.
Via
Business Wire
Small- To Mid-Cap Biotech Trades Poised For Gains
↗
February 01, 2025
On Monday, we called for a trading bottom in healthcare stocks. We also saw momentum picking for two Health Science sectors: small- to mid-cap biotechs, and MedTech. Here is a closer look at these...
Via
Talk Markets
Topics
ETFs
Stocks / Equities
Why the high growth investor may take a look at NATERA INC (NASDAQ:NTRA).
↗
January 24, 2025
Exploring high growth characteristics of NATERA INC (NASDAQ:NTRA). A fundamental and technical analysis of (NASDAQ:NTRA).
Via
Chartmill
Looking Into Natera's Recent Short Interest
↗
January 20, 2025
Via
Benzinga
The Analyst Verdict: Natera In The Eyes Of 14 Experts
↗
January 10, 2025
Via
Benzinga
Natera Announces Successful Readout of Randomized, Phase III CALGB (Alliance) / SWOG 80702 Clinical Trial in Colorectal Cancer
January 25, 2025
From
Natera, Inc.
Via
Business Wire
Natera to Present New Data at the 2025 ASCO GI Symposium
January 21, 2025
From
Natera, Inc.
Via
Business Wire
Why Top 4% Guardant Health Surged To A 13-Month High And Topped A Profit-Taking Zone
↗
January 21, 2025
The company is working to expand the uses and reimbursement for its blood-based tests for cancer.
Via
Investor's Business Daily
Moderna, GameStop And Snap Are Among Top Large-Cap Losers Last Week (Jan 13-Jan 17): Are The Others In Your Portfolio?
↗
January 19, 2025
Eleven large-cap stocks were the worst performers in the last week. Short positions announced for FTAI, revenue updates for MRNA, and price forecasts changed for GME, SNAP, RKLB, NTRA, LLY, ICLR, BNTX,...
Via
Benzinga
Why NASDAQ:NTRA qualifies as a high growth stock.
↗
January 03, 2025
Should you consider NATERA INC (NASDAQ:NTRA) for high growth investing?
Via
Chartmill
Exploring NASDAQ:NTRA's high growth characteristics.
↗
December 13, 2024
Why the high growth investor may take a look at NATERA INC (NASDAQ:NTRA).
Via
Chartmill
The End Of The 60/40 Portfolio
↗
January 17, 2025
Since bonds don't protect against stock declines, it's time for a different approach.
Via
Benzinga
Topics
Bonds
Nvidia To Rally Around 31%? Here Are 10 Top Analyst Forecasts For Friday
↗
January 17, 2025
Via
Benzinga
Natera CEO Steve Chapman Recognized as a 2024 Top Healthcare Technology CEO and BioTechnology Innovator of the Year
January 17, 2025
From
Natera, Inc.
Via
Business Wire
Natera Announces Innovation Roadmap, with Advancements in MRD and Early Cancer Detection
January 15, 2025
From
Natera, Inc.
Via
Business Wire
Looking Into Natera's Recent Short Interest
↗
December 02, 2024
Via
Benzinga
Natera Announces Preliminary Fourth Quarter and Full-Year Results for 2024
January 12, 2025
From
Natera, Inc.
Via
Business Wire
Here Are Billionaire Stanley Druckenmiller's 5 Biggest Stock Holdings
↗
January 09, 2025
Via
The Motley Fool
Natera to Participate in the 43rd Annual J.P. Morgan Healthcare Conference
January 07, 2025
From
Natera, Inc.
Via
Business Wire
Stanley Druckenmiller Dumps Street's Hottest AI Stocks — Here's What The Billionaire Investor Is Betting On Next
↗
December 24, 2024
Druckenmiller's Duquesne Family Office sold Nvidia and Palantir stocks while increasing stake in Teva Pharmaceutical, signaling a shift in investment focus.
Via
Benzinga
Topics
Artificial Intelligence
Here Are Billionaire Stanley Druckenmiller's 5 Biggest Stock Holdings
↗
December 21, 2024
Via
The Motley Fool
Stanley Druckenmiller's Top Holding Has Outperformed Its Sector By 252%
↗
December 20, 2024
Billionaire Stanley Druckenmiller's latest large wager on biotech company Natera Inc has paid off, with his stake now exceeding $575 million.
Via
Benzinga
Court Grants Natera’s Request to Include Additional Patent in its Lawsuit Against NeoGenomics
December 17, 2024
From
Natera, Inc.
Via
Business Wire
Natera Announces Enrollment of First Patients in SAGITTARIUS: a Randomized, Phase III Clinical Trial in Colon Cancer
December 12, 2024
From
Natera, Inc.
Via
Business Wire
Natera and MyOme Announce Launch of iPRS™ for Breast Cancer Risk Assessment
December 09, 2024
From
Natera, Inc.
Via
Business Wire
Clinical Validation Study on Natera’s Fetal RhD NIPT Published in Obstetrics & Gynecology
December 02, 2024
From
Natera, Inc.
Via
Business Wire
Natera Announces Medicare Coverage for Prospera™ in Single Lung Transplant Recipients
November 27, 2024
From
Natera, Inc.
Via
Business Wire
Natera to Present New SignateraTM Data in Multiple Abstracts at the San Antonio Breast Cancer Symposium
November 25, 2024
From
Natera, Inc.
Via
Business Wire
< Previous
1
2
3
4
5
6
7
8
9
...
19
20
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
